Algorithm for treatment-refractory schizophrenia

被引:0
|
作者
Koshino, Y [1 ]
机构
[1] Kanazawa Univ, Sch Med, Dept Neuropsychiat, Kanazawa, Ishikawa 9208640, Japan
关键词
algorithm; antipsychotic drug; augmentation; electroconvulsive treatment; treatment refractory schizophrenia;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
This algorithm for the treatment-refractory schizophrenia consists of nine lines. It starts from the revaluation of the diagnosis and checking the compliance 'Apparent' non efficacy due to poor compliance must be distinguished from 'authentic' non efficacy. Patients with good compliance and non efficacy go on to the next line. Line 3 includes addition of another neurolepic, a neuroleptic in a decanoate form, addition of an anti-parkinsonian drug and reduction of the neuroleptic dose. Line 5 is the neuroleptic augmentation strategy. The options of line 7 are electroconvulsive treatment, very high-dose neuroleptics, an investigational protocol drug, and a drug-free period. Finally, line 9 includes an investigational protocol drug and a drug-free period.
引用
收藏
页码:S9 / S13
页数:5
相关论文
共 50 条
  • [31] Heterogeneity of serotonergic response in treatment-refractory schizophrenia patients
    Lindenmayer, JP
    Adityanjee
    VitalHerne, M
    Bark, N
    Grochowski, S
    Moynihan, N
    BIOLOGICAL PSYCHIATRY, 1997, 42 (01) : 6 - 12
  • [32] Ursodeoxycholic acid augmentation in treatment-refractory schizophrenia: a case report
    Khosravi, Mohsen
    JOURNAL OF MEDICAL CASE REPORTS, 2020, 14 (01)
  • [33] CLOZAPINE RESPONSE IN TREATMENT-REFRACTORY FIRST-EPISODE SCHIZOPHRENIA
    SZYMANSKI, S
    MASIAR, S
    MAYERHOFF, D
    LOEBEL, A
    GEISLER, S
    POLLACK, S
    KANE, J
    LIEBERMAN, J
    BIOLOGICAL PSYCHIATRY, 1994, 35 (04) : 278 - 280
  • [34] AMISULPRIDE AUGMENTATION OF CLOZAPINE FOR TREATMENT-REFRACTORY SCHIZOPHRENIA: THE AMICUS STUDY
    Barnes, Thomas
    Leeson, Verity
    Paton, Carol
    Marston, Louise
    Osborn, David
    Kumar, Raj
    Keown, Patrick
    Zafar, Rameez
    Iqbal, Khalid
    Singh, Vineet
    Fridrich, Pavel
    Fitzgerald, Zachary
    Bagalkote, Hemant
    Haddad, Peter
    Husni, Mariwan
    Amos, Tim
    SCHIZOPHRENIA BULLETIN, 2017, 43 : S164 - S165
  • [35] Sodium nitroprusside in treatment-refractory schizophrenia: a case-report
    Froelich, F.
    Guillin, O.
    Alexanian, J.
    Fourdrinier, V.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S495 - S496
  • [36] Long-term efficacy of ziprasidone in treatment-refractory schizophrenia
    Potkin, SG
    Loebel, A
    Kane, J
    Siu, C
    NEUROPSYCHOPHARMACOLOGY, 2005, 30 : S269 - S269
  • [37] Ursodeoxycholic acid augmentation in treatment-refractory schizophrenia: a case report
    Mohsen Khosravi
    Journal of Medical Case Reports, 14
  • [38] Clozapine in treatment-refractory schizophrenia - Plasma level and duration of an adequate treatment trial
    Schulte, PFJ
    PSYCHOPHARMAKOTHERAPIE, 2003, 10 (03): : 102 - 111
  • [39] Olanzapine in treatment-refractory schizophrenia: Results of an open-label study
    Martin, J
    Gomez, JC
    GarciaBernardo, E
    Cuesta, M
    Alvarez, E
    Gurpegui, M
    JOURNAL OF CLINICAL PSYCHIATRY, 1997, 58 (11) : 479 - 483
  • [40] Treatment-refractory hypothyroidism
    Ramadhan, Abdulaziz
    Tamilia, Michael
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2012, 184 (02) : 205 - 209